Citius Oncology Inc. (CTOR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Oncology Inc.

    NASDAQ: CTOR · Real-Time Price · USD
    1.89
    0.01 (0.53%)
    At close: Oct 03, 2025, 3:59 PM
    1.86
    -1.59%
    After-hours: Oct 03, 2025, 06:05 PM EDT

    Citius Oncology Cash Flow Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022
    Net Income
    		 -21.15M -12.7M -5.43M
    Depreciation & Amortization
    		 n/a n/a n/a
    Stock-Based Compensation
    		 7.5M 1.97M n/a
    Other Working Capital
    		 12.91M 8.61M 4.74M
    Other Non-Cash Items
    		 n/a -601.3K -47.97K
    Deferred Income Tax
    		 576K 576K 576K
    Change in Working Capital
    		 13.2M 10.16M 4.86M
    Operating Cash Flow
    		 126.35K -601.3K -47.97K
    Capital Expenditures
    		 -5M 4.00 n/a
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 n/a -1.32M -67.32M
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 -5M n/a n/a
    Investing Cash Flow
    		 -5M -1.32M -67.32M
    Debt Repayment
    		 3.8M n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 1.07M 1.66M -383.84K
    Financial Cash Flow
    		 4.87M 1.66M 67.66M
    Net Cash Flow
    		 112.00 -256.43K 289.18K
    Free Cash Flow
    		 -4.87M -601.3K -47.97K

    Add to Watchlist